Healthcare Market Desk

Mice Model Market Share, Company Analysis and Forecast 2019-2026

Press release   •   Sep 17, 2019 10:53 EDT

The global mice model market size is expected to reach USD 3.79 billion by 2026, at a CAGR of 9.8% from 2019 to 2026.

This market is majorly driven by “continuing modification in mice model for cancers, immune diseases, and rare diseases; increasing devouring of personalized medicine propelling demand for humanized mice model; rising grants and investments for biological research; rising pharmaceutical R&D activities; and increasing focus of International Mouse Phenotyping Consortium (IMPC) and International Knockout Mouse Consortium (IKMC) on the development of embryonic stem cells as well as knockout and mutant mice.”

CRISPR-Cas9 gene editing technology with its ease to perform, versatility, and high efficiency has significantly improved the production of desired modified alleles. This technology has enabled rapid production of knockout, conditional alleles or mice carrying single point mutations, which mimic those in human patients, in only several weeks. Thus, this technology provides significant potential in near future.

Get Free Report Sample Copy for More Understanding@ https://www.visionresearchreports.com/report/sample/28876

The world mice model market is envisaged to be primarily advantaged by the growing investments in biomedical research which plays a vital role in pharmaceutical and healthcare sectors. Investment in biomedical research is considered to be a crucial determinant for gauging the level of research and development achieved by a nation. Mice models could attract a decent demand in such investments, which could eventually increase in the near future because of their diversified applications.

Recently, a mice model with fragile X syndrome was used to test the effect of metformin, a type 2 diabetes drug. The results revealed a reversal of brain and behavioral abnormalities in the mice model. According to the report offered herewith, the world mice model market could find extensive opportunities birthing from different type, specialty, and services segments.

The authors of the report have provided a vast study of the world mice model market in terms of several aspects such as business opportunities, restraining factors, key drivers, and vendor landscape. Readers are expected to gain a significant understanding of the market and plan for a better position therein.

Trends and Opportunities

The employment of mice models by the ALS Association for deep research on the disease amyotrophic lateral sclerosis (ALS) is regarded as a fine instance of the rising demand in the market. This is evident of the latest developments in various services and types of mice model that are anticipated to improve existing research procedures. The penetration of mice models in several medical research domains could be another factor strengthening the demand in the market.

Irrigation assay system, computer-generated simulations, and other alternative solutions incorporating a streamlined procedure and faster conclusion development process are foretold to impede the growth of the world mice model market. This could be owing to the efforts to reduce or restrict the requirement of animal models. However, studies of advanced diseases incorporating the application of new mice models are prognosticated to add to the growth of the market. Lung disease repair and other cutting-edge researches also cover the use of innovative mice models.

Request to Buy This Premium Report From here@ https://www.visionresearchreports.com/report/cart/28876

Geographical Analysis

Expert analysts foresee the international mice model market to mainly operate in key geographies such as Asia Pacific, Europe, North America, the Middle East and Africa, Latin America, and Rest of the World. In respect of revenue, North America could take a leading position in the market with a significant share secured under its belt. Narrowly followed by Asia Pacific, Europe is anticipated to be another region cementing a strong position in the market. Both these markets could be riding on their sophisticated biosciences research and well-established pharmaceutical sectors.

Nevertheless, the staggering shares in North America and Europe are predicted to lose their grip on the international mice model market in future on account a telling demand in Asia Pacific. Nearly half of the business for transgenic and knockout mice models could be taken up by Asia Pacific in Singapore, Malaysia, India, and China.

Companies Mentioned

Some of the important players studied in this research publication could be Harlan Laboratories, Inc., GenOway S.A., Deltagen, Inc., Crescendo Biologics Limited, and Charles River Laboratories. A quality analysis of the key companies operating in the worldwide mice model market is expected to help participants to stay watchful and make informed decisions in their business operations.

Report Scope:

This research report categorizes the global mice model market into the following segments:

By Model Type

  • Outbred Mice
  • Inbred Mice
  • Knockout/Genetically Modified Mice
  • Hybrid/Congenic Mice
  • Conditioned/Surgically Modified Mice
  • Immunodeficient Mice

By Service

  • Breeding
  • Cryopreservation
  • Quarantine
  • Rederivation
  • Model-in-licensing
  • Genetic Testing
  • Other Services

By Therapeutic Area

  • ONCOLOGY STUDIES
  • IMMUNOLOGY AND INFLAMMATION STUDIES
  • DIABETES STUDIES
  • CARDIOVASCULAR STUDIES
  • CENTRAL NERVOUS SYSTEM (CNS) STUDIES
  • Other disease studies

By Technology

  • CRISPR/CAS9
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Other Technologies

By Care Product

  • Cages
  • Feed
  • Bedding
  • Other Care Products

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Request to Buy This Premium Report From here@ https://www.visionresearchreports.com/report/cart/28876

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.2.1 Secondary Research
1.2.2 Primary Research
1.3 Market Segmentation
1.4 Assumptions and Stipulations

Chapter 2 Executive Summary
2.1 Global Mice Consumption, 2016
2.2 Market Snapshot: Global Mice Model Market (2018 and 2026E)
2.3 Global Mice Model Market, by Type, 2018 (USD Million)
2.4 Global Mice Model Market, by Application, 2018 (USD Million)
2.5 Global Mice Model Market, by Services, 2018 (USD Million)
2.6 Comparative Analysis: Global Mice Model Market Revenue, by Geography, 2018 and 2026E (Value %)

Chapter 3 Global Mice Model Market: Market Overview
3.1 Overview
3.1.1 Proportion of Mice as Compared to Total Animal Used in Research Globally (Value %), 2011
3.2 End-users of Mice Models
3.2.1 End-user Analysis of Mice Model Market (Value %), 2016
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Growing investment in biomedical research
3.3.1.2 Biomedical Research Growth Rate, 2007–2012, (%)
3.3.1.3 Growing number of advanced mice model would increase applicability and acceptability
3.3.1.4 Personalized in vivo analysis mice models would fuel demand for mice models in personalized medicine
3.3.2 Restraints
3.3.2.1 Rising concern about animal use across the globe would restrain the market
3.3.2.2 Development of alternative technologies
3.3.3 Opportunities
3.3.3.1 Countries in Asia offer immense growth opportunities in the mice model market
3.4 Event Impact Assessment: Mice Model Market
3.5 Market Attractiveness Analysis: Global Mice Model Market
3.5.1 Mice Model Market Analysis: The U.S. and China
3.5.2 Market Attractiveness Analysis: Global Mice Model Market, by Geography
3.5.3 Growth-Share Matrix Analysis: Global Mice Model Market, by Type
3.6 Competitive Landscape
3.6.1 Global Market Share Analysis, by Key Players, 2016 (Value %)
3.6.2 Global Market Share Analysis, by Key Players, 2018 (Value %)
3.6.3 Heat Map Analysis, by Key Geography, 2018 (Market Share)
3.6.4 Heat Map Analysis, by Key Geography, 2018 (Market Growth)

Chapter 4 Global Mice Model Market, by Type
4.1 Overview
4.1.1 Global Mice Model Market, by Type, 2016–2018 (USD Million)
4.1.2 Global Mice Model Market, by Model Type, 2019E–2026E (USD Million)
4.2 Transgenic Mice Model
4.2.1 Transgenic Mice Applications in Various Specialties (%)
4.2.2 Global Transgenic Mice Model Market, 2016–2026E (USD Million)
4.3 Hybrid/Congenic Mice Model
4.3.1 Global Hybrid/Congenic Mice Model Market, 2016–2026E (USD Million)
4.4 Knockout Mice Model
4.4.1 Knockout Mice Applications in Various Specialties, 2018 (%)
4.4.2 Global Knockout Mice Model Market, 2016–2026E (USD Million)
4.5 Carcinogen-induced and Spontaneous Mice Model
4.5.1 Global Carcinogen-induced and Spontaneous Mice Model Market, 2016–2026E (USD Million)
4.6 Outbred Mice Model
4.6.1 Global Outbred Mice Model Market, 2016–2026E (USD Million)
4.7 Inbred Mice Model
4.7.1.1 Inbred Mice Applications in various Specialties (%), 2018
4.7.1.2 Global Inbred Mice Model Market, 2016–2026E (USD Million)
4.8 Transplantation Mice Model
4.8.1 Global Transplantation Mice Model Market, 2016–2026E (USD Million)
4.9 Conditioned/Surgically Modified Mice Model
4.9.1 Global Conditioned/Surgically Modified Mice Model Market, 2016–2026E (USD Million)

Chapter 5 Global Mice Model Market, by Specialty
5.1 Overview
5.1.1 Global Mice Model Market, by Application, 2016–2018 (USD Million)
5.1.2 Global Mice Model Market, by Application, 2019E–2026E (USD Million)
5.2 Immunology
5.2.1 Global Immunology Mice Model Market, 2016–2026E (USD Million)
5.2.2 Number of Immunology Mice Models, by Major Companies
5.2.3 Immunology Mice Model Market Share, by Model Type, 2018
5.3 Central Nervous System (CNS)
5.3.1 Global CNS Mice Model Market, 2016–2026E (USD Million)
5.3.2 Number of CNS Mice Models, by Major Companies
5.3.3 CNS Mice Model Market Share, by Model Type, 2018
5.4 Oncology
5.4.1 Global Oncology Mice Model Market, 2016–2026E (USD Million)
5.4.2 Number of Oncology Mice Models, by Major Companies
5.4.3 Oncology Mice Model Market Share, by Model Type, 2018
5.5 Cardiovascular
5.5.1 Global Cardiovascular Mice Model Market, 2016–2026E (USD Million)
5.5.2 Number of Cardiovascular Mice Models, by Major Companies
5.5.3 Cardiovascular Mice Model Market Share, by Model Type, 2018
5.6 Diabetes
5.6.1 Global Diabetes Mice Model Market, 2016–2026E (USD Million)
5.6.2 Number of Diabetes Mice Models, by Major Companies
5.6.3 Diabetes Mice Model Market Share, by Model Type, 2018
5.7 Metabolism & Regulation
5.7.1 Global Metabolism & Regulation Mice Model Market, 2016–2026E (USD Million)
5.7.2 Metabolism & Regulation Mice Models Market Share, by Model Type, 2018

Chapter 6 Global Mice Model Market, by Services
6.1 Overview
6.1.1 Global Mice Model Market, by Services, 2016–2018 (USD Million)
6.1.2 Global Mice Model Market, by Services, 2019E–2026E (USD Million)
6.2 Breeding and Rederivation Services
6.2.1 Global Breeding and Rederivation Services Market, 2016–2026E (USD Million)
6.3 Cryopreservation and Cryorecovery Services
6.3.1 Global Cryopreservation and Cryorecovery Services Market, 2016–2026E (USD Million)
6.4 Quarantine Services
6.4.1 Global Quarantine Services Market, 2016–2026E (USD Million)
6.5 Genetic Testing Services
6.5.1 Global Genetic Testing Services Market, 2016–2026E (USD Million)
6.6 Model In-licensing Services
6.6.1 Global Model In-licensing Market, 2016–2026E (USD Million)
6.7 In vivo and In vitro Pharmacology Services
6.7.1 Global In vivo and In vitro Pharmacology Services Market, 2016–2026E (USD Million)
6.8 Genetically Engineered Model Services
6.8.1 Genetically Engineered Model Services
6.9 Other Services (Surgical and Line Rescue)
6.9.1 Global Other Services Market, 2016–2026E (USD Million)

Chapter 7 Global Mice Model Market, by Geography
7.1 Overview
7.1.1 Mice Model Market Share Index, 2018 (On Scale of 1 to 5)
7.1.2 Global Mice Model Market, Growth Index, 2019–2026 (On a Scale of 1 to 5)
7.1.3 Global Mice Model Market Revenue, by Geography, 2016–2026 (USD Million)
7.2 North America
7.2.1 North America Population, GDP, and Health care Expenditure, 2011–2016
7.2.2 North America Mice Model Market Revenue, 2016–2026E (USD Million
7.2.3 U.S.
7.2.3.1 U.S. Mice Model Market, 2016–2026E (USD Million)
7.2.4 Canada
7.2.4.1 Comparative Analysis: Proportion of Animals Used in Research in Canada, 2011 and 2012 (Value %)
7.2.4.2 Canada Mice Model Market, 2016–2026E (USD Million)
7.3 Europe
7.3.1 Europe Population, GDP, and Health care Expenditure, 2011–2016
7.3.2 Europe Mice Model Market Revenue, 2016–2026E (USD Million)
7.3.3 Germany
7.3.3.1 Germany Mice Model Market Revenue, 2016–2026E (USD Million)
7.3.4 U.K.
7.3.4.1 U.K. Mice Model Market Revenue, 2016–2026E (USD Million)
7.3.5 Rest of Europe
7.3.5.1 Rest of Europe Mice Model Market Revenue, 2016–2026E (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Population, GDP, and Healthcare Expenditure, 2011–2016
7.4.2 Asia Pacific Mice Model Market Revenue, 2016–2026E (USD Million)
7.4.3 Japan
7.4.3.1 Japan Mice Model Market, 2016–2026E (USD Million)
7.4.4 China
7.4.4.1 China Mice Model Market, 2016–2026E (USD Million)
7.4.5 Rest of Asia Pacific
7.4.5.1 Rest of Asia Pacific Mice Model Market, 2016–2026E (USD Million)
7.5 Latin America
7.5.1 Latin America Population, GDP, and Health care Expenditure, 2011 – 2016
7.5.2 Latin America Mice Model Market, 2016–2026E (USD Million)
7.5.3 Brazil
7.5.3.1 Brazil Mice Model Market, 2016–2026E (USD Million)
7.5.4 Mexico
7.5.4.1 Mexico Mice Model Market, 2016–2026E (USD Million)
7.5.5 Rest of Latin America
7.5.5.1 Rest of Latin America Mice Model Market, 2016–2026E (USD Million)
7.6 Middle East & North Africa (MENA)
7.6.1 MENA Mice Model Market, 2016–2026E (USD Million)
7.6.2 Saudi Arabia (KSA)
7.6.2.1 Saudi Arabia Mice Model Market, 2016–2026E (USD Million)
7.6.3 UAE
7.6.3.1 UAE Mice Model Market, 2016–2026E (USD Million)
7.6.4 Israel
7.6.4.1 Israel Mice Model Market, 2016–2026E (USD Million)
7.6.5 Rest of MENA
7.6.5.1 Rest of MENA Mice Model Market, 2016–2026E (USD Million)
7.7 Rest of the World (RoW)
7.7.1 RoW Population, GDP, and Health care Expenditure, 2011–2016
7.7.2 Rest of World Mice Model Market, 2016–2026E (USD Million)

Chapter 8 Recommendations
8.1 Focus on collaborations with contract research organizations or strengthening in-house research capabilities
8.2 Sustaining pricing pressures in a declining global economic scenario
8.3 Investing in emerging markets such as India, China, and Brazil

Chapter 9 Company Profiles
9.1 Charles River Laboratories International, Inc.
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Crescendo Biologics Limited
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Deltagen, Inc.
9.3.1 Company Overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.3.5 Recent Developments
9.4 genOway S.A.
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Harbour Antibodies BV
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Harlan Laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 ImmunoGenes AG
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 SAGE Labs
9.8.1 Company Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 The Jackson Laboratory
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Taconic Biosciences, Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 TransGenic, Inc.
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments

Request to Buy This Premium Report From here@ https://www.visionresearchreports.com/report/cart/28876